DmitryAMezentsevMD

PubMed

• 10 citations
  A Phase II Study of Neoadjuvant and Adjuvant Chemotherapy with 5-Fluorodeoxyuridine, Leucovorin, Oxaliplatin and Docetaxel in the Treatment of Previously Untreated Adv...
  Naveenraj L. Solomon, Dmitry Mezentsev, Isildinha M. Reis, Myra Lima, Joyce Rios, Eli Avisar, Dido Franceschi, Alan S. Livingstone, Lisa Podolsky, Bach Ardalan> ;Japanese Journal of Clinical Oncology. 2011 Apr 1
• 34 citations
  A Phase I Study of 5-Fluorouracil/Leucovorin and Arsenic Trioxide for Patients with Refractory/Relapsed Colorectal Carcinoma
  Bach Ardalan, Pochi R. Subbarayan, Yipsel Ramos, Michael A. Gonzalez, Anthony P. Fernandez, Dmitry Mezentsev, Isildinha Reis, Robert Duncan, Lisa Podolsky, Kelvin P. L...> ;Clinical Cancer Research. 2010 Jun 1
• Phase II study of bevacizumab (B), camptosar (I), high-dose 24-hour continuous intravenous infusion of floxuridine (F) and leucovorin (L) in patients with previously u...
  Ardalan B, Feagans M, Mezentsev D, Jones C, Subbarayan PR, Walker G, Sapp M, Stephenson K, Ness J, Franceschi D, Livingstone A> ;J. Clin. Oncol.. 2009-05-20
• Phase II study: Neo-adjuvant chemotherapy (NAC) with fudr (F), leucovorin (L), oxaliplatin (O), and docetaxel (D) (FLOD) in chemo-naïve operable esophageal adenocarcin...
  Ardalan B, Spector S, Mezentsev D, Molina MA, Reis I, Ganjei-Azar P, Sapp M, Rios J, Franceschi D, Livingstone AS> ;J. Clin. Oncol.. 2008-05-20
• 15 citations
  Asymptomatic muscle metastases from esophageal adenocarcinoma.
  Olga N. Kozyreva, Dmitry Mezentsev, David R. King, Carmen Gomez-Fernandez, Bach Ardalan, Alan S. Livingstone> ;Journal of Clinical Oncology. 2007 Aug 20
• 12 citations
  Neoadjuvant, Surgery and Adjuvant Chemotherapy without Radiation for Esophageal Cancer
  Bach Ardalan, Seth A. Spector, Alan S. Livingstone, Dido Franceschi, Dmitry Mezentsev, Mayra Lima, C. P. Bowen-Wells, L. Sparling, Eli Avisar, Michelle Sapp, Joyce Rio...> ;Japanese Journal of Clinical Oncology. 2007 Aug 1
• Join now to see all